文献速递颈动脉与弓上血管

整合式卒中诊疗系统能否改善症状性颈动脉狭窄患者从症状到手术的时间?单中心决策树分析

Do Integrated Systems of Stroke Care Improve Symptom to Surgery Times in Patients with Symptomatic Carotid Stenosis? A Single Centre Decision Tree Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-08-30

该单中心决策树分析纳入2011年4月1日至2016年3月31日期间接受颈动脉内膜切除术的376例患者,比较整合式卒中诊疗路径(243例)与标准紧急转诊路径(133例)的症状至手术时间、成本效果与生活质量。整合路径中位症状至手术时间11天,标准路径15天(p < .001);整合路径围手术期卒中死亡率2.1%,标准路径1.5%(卡方=0.14,p = .73),无显著差异。整合路径CEA额外增加0.13个质量调整生命年(整合路径0.64 QALYs vs 标准路径0.51 QALYs),并带来2203.4英镑的增量终生成本效益。

要点

  • 整合路径中位症状至手术时间11天,标准路径15天(p < .001)。
  • 围手术期卒中死亡率整合路径2.1% vs 标准路径1.5%,无显著差异(p = .73)。
  • 整合路径CEA增加0.13 QALYs(0.64 vs 0.51),增量终生成本效益2203.4英镑。

核心结论

  • 整合式卒中诊疗系统具有成本效益,并与质量调整生命年的显著改善相关。

研究设计与样本

  • 单中心决策树分析,纳入2011年4月1日至2016年3月31日期间在区域血管中心接受颈动脉内膜切除术的患者,从国家血管注册库(NVR)识别。
  • 共376例患者,其中243例经整合式卒中路径管理,133例经标准紧急转诊路径管理。
  • 使用牛津卒中风险计算器计算每例患者药物治疗的卒中风险。
  • 构建决策分析马尔可夫过程模型,评估标准路径与整合路径下CEA对比药物治疗的成本效果,考察终生成本与健康获益。

主要发现

  • 整合路径中位症状至手术时间11(0-66)天,标准路径15(3-90)天(p < .001)。
  • 围手术期卒中死亡率整合路径2.1% vs 标准路径1.5%(卡方=0.14,p = .73),无显著差异。
  • 整合路径CEA使质量调整预期寿命额外增加0.13(整合路径0.64 QALYs vs 标准路径0.51 QALYs)。
  • 整合路径与2203.4英镑的增量终生成本效益相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to examine the impact of an integrated system of stroke care on symptom to surgery times, cost-effectiveness, and quality of life measures in patients with symptomatic carotid stenosis. METHODS: Patients who underwent carotid endarterectomy (CEA) in a regional vascular centre between April 1, 2011, and March 31, 2016, were identified from the National Vascular Registry (NVR). Risk of stroke on medical therapy for each patient was calculated using the Oxford stroke risk calculator. Symptom to surgery times were compared among patients referred from a stroke service providing an integrated stroke care and the stroke service in an adjacent NHS trust which provides standard urgent referral pathway. A decision analytic Markov process model was constructed to determine the cost-effectiveness of CEA versus medical treatment in patients who followed the standard and integrated pathways. This model examined the lifetime costs and health benefits of CEA through each pathway. RESULTS: A total of 376 patients underwent CEA, of whom 243 were managed through the integrated stroke pathway and 133 through the standard urgent referral pathway. Median symptom to surgery time was 11 (0-66) days for the former and 15 (3-90) days for the latter (p < .001). There was no significant difference in peri-operative stroke death rate between integrated (2.1%) and standard (1.5%) pathways (chi-square = 0.14, p = .73). CEA through the integrated pathway improved quality adjusted life expectancy by an additional 0.13 (0.64 QALYs [integrated pathway] to 0.51 QALYs [standard pathway]) and was associated with an incremental lifetime cost benefit of £2203.4. CONCLUSIONS: An integrated stroke system of care is cost-effective and associated with significant improvements in quality adjusted life years.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Mofidi R, Thomas M, Wong PF, et al. Do Integrated Systems of Stroke Care Improve Symptom to Surgery Times in Patients with Symptomatic Carotid Stenosis? A Single Centre Decision Tree Analysis. Eur J Vasc Endovasc Surg. 2018. PMID: 30174270. doi:10.1016/j.ejvs.2018.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。